General Practice in Missouri City, TX
3 verified general practice doctors in Missouri City.
General practice physicians provide broad, first-contact medical care for common conditions across all age groups.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Paul Shrode, MD
General Practice
CMS Open Payments· $249,658 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$249,658
Total received
120
Transactions
1
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total is higher than 100% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Paul Shrode do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ifeoma Ude-Okoro, MD
General Practice
CMS Open Payments· $2,023 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,023
Total received
22
Transactions
17
Paying companies
Top paying companies
Among the 13,209 general practice doctors we've analyzed, about 25% received any industry payment (median $145 among those who did). This doctor's total is higher than 98% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US general practice doctors.
Payments to Ifeoma Ude-Okoro do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jeffrey Hubbard, MD
General Practice
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.